# Jumpstart Ventures

> Jumpstart Ventures is a VC fund in Chicago backing Software and Health Care. See 71 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Chicago, United States
- Total investments: 71
- Last investment: Apr 2026
- Lead investor: 13%
- Last fund: Mar 2025
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/jumpstart-vc
- Website: http://www.jumpstart.vc/

JumpStart Ventures is an investment fund built to partner with entrepreneurs solving problems that need intelligent innovation and ambitious solutions.The fund invests in founders with humble invincibility and purposeful creativity launching companies that positively impact the world around them.

## Contacts

5 contacts available for Jumpstart Ventures. Shizune tracks 3 team members at Jumpstart Ventures. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/jumpstart-ventures?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $750k–$6M |
| Series A | $2.3M–$11M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Software | 16 | 23% |
| Health Care | 16 | 23% |
| Information Technology | 10 | 14% |
| SaaS | 9 | 13% |
| Mobile | 7 | 10% |

101 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 22 | 31% |
| Series A | 15 | 21% |
| Funding Round | 9 | 13% |
| Series B | 8 | 11% |
| Series C | 4 | 6% |

8 stages tracked in total.

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Jim Demas | Partner | 0 | https://shizune.co/investors/profile/jim-demas |
| Rishi Shah | Founding Partner & Managing Director | 3 | https://shizune.co/investors/profile/rishi-shah-2 |
| Shradha Agarwal | Founder & Managing Partner | 1 | https://shizune.co/investors/profile/shradha-agarwal |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Ethermed | Ethermed uses AI to solve Prior Authorizations for providers, payers and technology partners, a $500 billion paperwork problem tangential to every healthcare transaction. That seed enables us to stitch together adversarial players and the siloed data ecosystem, to automate public health interventions across the entire spectrum of care and SDOH.Ethermed’s SaaS platform eliminates the healthcare barriers between payers and providers. Our unique algorithm works within existing technology by scanning clinical and non-clinical data and automatically pre-filling and submitting prior authorizations. Ethermed automatically handles authorizations with no human involvement; removes increasing volumes of administrative overhead, and frees up staff to focus on care and revenue priorities - liberating UM teams from hours of clerical work so they can focus on what matters most- patient care. | $8.5M | Series A | Apr 16, 2026 |  |
| TandemStride | TandemStride provides genuine, individualized support to survivors and their loved ones, whether in the form of a peer mentor with training, resources, or just someone who knows what it's like to be in recovery. | $5.5M | Seed | Sep 08, 2025 |  |
| OnStation | OnStation is the leading digital stationing platform for road construction. Founded in 2013, OnStation replaces physical survey stakes, paper field logs, and GPS rovers with live, station-referenced location and documentation on any phone — no special hardware required.Field crews, CEI inspection teams, and state DOT agencies use OnStation toknow exactly where they are on a project, document work in real time with geo-referenced photos and notes, and build defensible records for pay applications, change orders, and DOT closeout. Every photo, flag, and note is automatically anchored to a precise station reference and timestamp.OnStation is used on more than 5,000 road construction projects by over 400 contractor organizations and 16+ state DOT agencies across the United States. Customer retention is approximately 97%. The platform is SOC 2 Type 2 certified.Key outcomes reported by customers include $18,000 saved per density technician per year (Mathy Construction), guardrail location disputes resolved in seconds vs. hours (RS&H — I-4 Corridor), and elimination of GPS rover dependency from daily field workflows (APEX Engineering). | $8.5M | Series A | Jun 10, 2024 |  |
| Abre | Abre.io is K-12’s #1 administration platform to support the whole child. Developed by two educators tired of not providing their stakeholders the optimal technology experience, Abre.io is a true education platform that connects what matters most to students, families, staff, and community partners. Abre.io helps schools increase student success allwhile saving money and providing a better connected experience through tailored communications, integrated data, and full interoperability. https://abre.io/ | $24M | Series A | Apr 11, 2024 |  |
| Thrivable | Thrivable is the strategic patient insights partner for life sciences and healthcare organizations in the cardiometabolic space. We uncover what truly drives patient behavior, so teams can increase adoption, improve retention, and make decisions with confidence. By delivering trustworthy, data-backed insights grounded in the voice of the patient,we bring lived experience directly into healthcare decision-making, helping organizations move beyond assumptions and act with clarity.Thrivable provides the following products: Strategic Research Studies - Incorporate the voice of your target patient into your annual learning plan using a mix of planned and on-demand pulse, quantitative, and qualitative research projects.Market Monitoring - Truly understand how patients are impacted by receiving continuous insights about your target patient behaviors as market dynamics change, all with little effort on your end.Patient Communities - Get richer feedback than traditional research by conducting async interviews and focus groups with your target patient audience. | $6M | Seed | Dec 06, 2023 |  |
| Invirsa | Invirsa is developing a unique, broad platform based on a naturally occurring small molecule (INV-102) that has demonstrated enhanced immune response to infection. INV-102 not only reduces viral infection, and potentially bacterial replication, it also reduces inflammation, while enhancing the bodies wound healing response. Invirsa'stechnology is first being developed in the ophthalmology and pulmonary space.Invirsa’s technology has the potential to be a first line therapy for common infectious diseases, whether it's the 100 million viral pulmonary infections or the 5 million infectious conjunctivitis cases that occur every year in the US alone. | $7.7M | Series B | Jun 14, 2023 |  |
| Axuall | Axuall is a workforce intelligence company built on a national real-time practitioner data network. Axuall offers a holistic approach to workforce analytics, including an integrated platform for driving smarter decisions and quickly onboarding providers. It enables healthcare systems, staffing firms, telehealth, and health plans to reduceonboarding and enrollment time while also providing unique, powerful data insights for network planning, analytics, and reporting. | $20M | Series B | May 31, 2023 |  |
| Bloomfilter | Bloomfilter is a developer of an enterprise software planning application. Bloomfilter helps software executives and leaders illuminate the path to software project success through our platform. | $5.5M | Seed | May 04, 2023 |  |
| Octet Scientific | Octet Scientific addresses an unmet need for support chemistry in the Zinc Battery industry. Octet Scientific, Inc. was founded in 2017 | $1M | Seed | Apr 25, 2023 |  |
| Native AI | The always-on market intelligence platform that helps you understand, innovate, and create ideal experiences for your customers. Our proprietary, generative AI efficiently translates customer and market data into specific, continuous recommendations in a way that's fast, cost-effective, and easy to use.With Native, you'll be able tomeasurable improvements to products, customer experience, marketing, and revenue. | $3.5M | Seed | Apr 06, 2023 |  |

10 of 71 investments shown.

## Co-investors
- [Listen](https://shizune.co/investors/profile/listen-llc) — VC Fund, 7 deals together
- [OCA Ventures](https://shizune.co/investors/profile/oca-ventures) — VC Fund, 6 deals together
- [Chicago Ventures](https://shizune.co/investors/profile/chicago-ventures) — VC Fund, 5 deals together
- [JobsOhio](https://shizune.co/investors/profile/jobsohio) — VC Fund, 5 deals together
- [North Coast Ventures](https://shizune.co/investors/profile/north-coast-angel-fund) — VC Fund, 5 deals together
- [Everywhere Ventures](https://shizune.co/investors/profile/everywhere-ventures) — VC Fund, 4 deals together

## Similar investors

### Similar industry
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Forerunner](https://shizune.co/investors/profile/forerunner-ventures) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## Featured in investor lists
- [Fashion VC Funds](https://shizune.co/investors/fashion-vc-funds)
- [Fashion Investors in United States](https://shizune.co/investors/fashion-investors-united-states)
- [Fashion VC Funds in United States](https://shizune.co/investors/fashion-vc-funds-united-states)

## FAQ

### What does Jumpstart Ventures invest in?

Jumpstart Ventures invests primarily in Software, Health Care and Information Technology startups, most often at Seed and Series A stage. Most of the 71 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Jumpstart Ventures's check size?

Jumpstart Ventures typically joins rounds of $750k–$6M at Seed and $2.3M–$11M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Jumpstart Ventures participates in.

### How do I contact Jumpstart Ventures?

Public channels for Jumpstart Ventures include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Jumpstart Ventures?

The team at Jumpstart Ventures includes Jim Demas (Partner), Rishi Shah (Founding Partner & Managing Director) and Shradha Agarwal (Founder & Managing Partner). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co